H
Henry Shibata
Researcher at McGill University
Publications - 11
Citations - 3041
Henry Shibata is an academic researcher from McGill University. The author has contributed to research in topics: Breast cancer & Lumpectomy. The author has an hindex of 9, co-authored 9 publications receiving 2964 citations.
Papers
More filters
Journal ArticleDOI
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.
Bernard Fisher,Madeline Bauer,D. Lawrence Wickerham,Carol K. Redmond,Edwin R. Fisher,Anatolio B. Cruz,Roger S. Foster,Bernard Gardner,Harvey J. Lerner,Richard G. Margolese,Roger Poisson,Henry Shibata,Herbert Volk +12 more
TL;DR: Results reveal that there is a risk in combining all patients with ≫4 positive nodes into a single group, and it is concluded that nodal status still remains the primary prognostic discriminant.
Journal ArticleDOI
Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors
Bernard Fisher,James J. Dignam,John Bryant,Arthur DeCillis,D. Lawrence Wickerham,Norman Wolmark,Joseph P. Costantino,C Redmond,Edwin R. Fisher,David M. Bowman,Luc Deschenes,Nikolay V. Dimitrov,Richard G. Margolese,André Robidoux,Henry Shibata,Jose J. Terz,Ahg Paterson,Merrill I. Feldman,William B. Farrar,James Evans,H. Lavina A. Lickley +20 more
TL;DR: The outcome of patients in the B-14 trial through 10 years of follow-up indicated that tamoxifen therapy provided substantial benefit to patients with early stage disease, and questions arose about how long the observed benefit would persist.
Journal ArticleDOI
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Bernard Fisher,James J. Dignam,Birol Emir,John Bryant,Arthur DeCillis,Norman Wolmark,D. Lawrence Wickerham,Nikolay V. Dimitrov,Neil Abramson,James N. Atkins,Henry Shibata,Luc Deschenes,Richard G. Margolese +12 more
TL;DR: Findings from this and other NSABP studies indicate that patients with breast cancer who meet NSABP protocol criteria, regardless of age, lymph node status, tumor size, or estrogen receptor status, are candidates for chemotherapy.
Journal ArticleDOI
Depression and body image following mastectomy and lumpectomy.
Jean-Claude Lasry,Jean-Claude Lasry,Richard G. Margolese,Roger Poisson,Henry Shibata,David Fleischer,Denise Lafleur,Sandra Legault,Suzanne S. Taillefer +8 more
TL;DR: The psychological and social adjustment following total and partial mastectomy in a group of patients randomly assigned to one or the other operation (National Surgical Adjuvant Breast Protocol--B-06) is investigated.
Journal ArticleDOI
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)
Bernard Fisher,Andrew G. Glass,Carol K. Redmond,Edwin R. Fisher,Bruce A. Barton,Emillie Such,Paul P. Carbone,Steven G. Economou,Roger S. Foster,Robert Frelick,Harvey J. Lerner,Martin Levitt,Richard G. Margolese,John MacFarlane,David Plotkin,Henry Shibata,Herbert Volk +16 more
TL;DR: Findings from the second protocol confirm those previously reported indicating that L‐PAM lengthens the disease free interval following mastectomy and lend support to the thesis that since breast cancer is an eponym to describe a heterogeneous group of tumors residing in a heterogenous group of women, it is unlikely that uniformly qualitative and quantitative systemic regimens of therapy will be required for every patient.